253 related articles for article (PubMed ID: 8758204)
1. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
2. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
3. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples.
Lauritzen AF; Ralfkiaer E
APMIS; 1991 Jul; 99(7):631-9. PubMed ID: 2069805
[TBL] [Abstract][Full Text] [Related]
4. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
7. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
[TBL] [Abstract][Full Text] [Related]
9. Detection of B- and T-cells in paraffin-embedded tissue sections. Diagnostic utility of commercially obtained 4KB5 and UCHL-1.
Clark JR; Williams ME; Swerdlow SH
Am J Clin Pathol; 1990 Jan; 93(1):58-69. PubMed ID: 2403743
[TBL] [Abstract][Full Text] [Related]
10. Antigen preservation in infarcted lymphoid tissue. A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues.
Norton AJ; Ramsay AD; Isaacson PG
Am J Surg Pathol; 1988 Oct; 12(10):759-67. PubMed ID: 3262314
[TBL] [Abstract][Full Text] [Related]
11. [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
Voigt JJ; Vinel JP; Caverivière P; Pradère B; Chittal S; al Saati T; Calès P; Delsol G
Gastroenterol Clin Biol; 1989 Apr; 13(4):343-52. PubMed ID: 2661293
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological analysis of the immunoreactivity of normal lymphoid cells and lymphomas with the monoclonal antibody OPD4.
O'Grady J; Blaikie AJ; Howie SE; Salter DM; Krajewski AS
J Pathol; 1991 Jun; 164(2):119-25. PubMed ID: 2072211
[TBL] [Abstract][Full Text] [Related]
13. Pattern of malignant lymphomas in Rwanda.
Ngendahayo P; Schmauz R
Bull Cancer; 1992; 79(11):1087-96. PubMed ID: 1302535
[TBL] [Abstract][Full Text] [Related]
14. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness.
Krishnan J; Wallberg K; Frizzera G
Am J Surg Pathol; 1994 May; 18(5):455-65. PubMed ID: 8172320
[TBL] [Abstract][Full Text] [Related]
15. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
16. The distinction of Hodgkin's disease from T cell lymphoma.
Banks PM
Semin Diagn Pathol; 1992 Nov; 9(4):279-83. PubMed ID: 1480849
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease--an entity?].
Hansmann ML
Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
20. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
Schmidt U; Metz KA; Leder LD
Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
